aCGH Impacts Survival in Plasma Cell PTLD

NCT02984215 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2016-12-06

No results posted yet for this study

Summary

Plasma-cell post-transplantation lymphoproliferative disorders (PC-PTLD) are rare monomorphic PTLD divided into plasma cell myeloma (PCM) and plasmacytoma-like lesion (PLL) PTLD. To date, there is no exhaustive published cytogenetic data on PC-PTLD. The investigators report array-based comparative genomic hybridization (aCGH) of 10 cases of PCM and PLL-PTLD.

Conditions

  • Post-transplantation Lymphoproliferative Disorders

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-01-31
Primary Completion
2012-01-31
Completion
2016-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02984215 on ClinicalTrials.gov